ArticlePloS one2018

Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naïve patients in China.

Yun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.